Aljian Capital Management LLC Acquires Shares of 11,030 CVS Health Co. (NYSE:CVS)

Aljian Capital Management LLC purchased a new position in shares of CVS Health Co. (NYSE:CVS - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 11,030 shares of the pharmacy operator's stock, valued at approximately $694,000.

A number of other institutional investors have also recently made changes to their positions in CVS. Livelsberger Financial Advisory purchased a new position in shares of CVS Health in the 3rd quarter worth about $31,000. Crewe Advisors LLC purchased a new stake in CVS Health during the 1st quarter valued at $40,000. Reston Wealth Management LLC bought a new position in shares of CVS Health during the third quarter valued at about $32,000. Kathleen S. Wright Associates Inc. bought a new stake in shares of CVS Health in the third quarter worth about $33,000. Finally, First Community Trust NA grew its position in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator's stock worth $33,000 after buying an additional 302 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

CVS Health Price Performance

Shares of CVS traded up $2.89 during midday trading on Monday, hitting $56.08. 18,702,738 shares of the company traded hands, compared to its average volume of 11,374,905. CVS Health Co. has a 52 week low of $52.71 and a 52 week high of $83.25. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The firm has a 50 day moving average of $59.19 and a 200-day moving average of $58.60. The stock has a market cap of $70.57 billion, a price-to-earnings ratio of 14.23, a PEG ratio of 0.92 and a beta of 0.55.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business had revenue of $95.43 billion for the quarter, compared to analysts' expectations of $92.72 billion. During the same period in the prior year, the firm earned $2.21 EPS. The company's revenue for the quarter was up 6.3% on a year-over-year basis. On average, analysts forecast that CVS Health Co. will post 5.48 EPS for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.74%. The ex-dividend date was Monday, October 21st. CVS Health's payout ratio is 67.51%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft decreased their price target on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating for the company in a research note on Friday, August 9th. Evercore ISI boosted their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a report on Tuesday, October 8th. StockNews.com downgraded shares of CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday. Truist Financial upped their price target on CVS Health from $66.00 to $76.00 and gave the stock a "buy" rating in a research note on Friday, October 11th. Finally, Wells Fargo & Company upgraded CVS Health from an "equal weight" rating to an "overweight" rating and lifted their price objective for the company from $60.00 to $66.00 in a research note on Monday. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $72.78.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.